Rachel D Savage1,2, Jessica D Visentin1, Susan E Bronskill1,2,3, Xuesong Wang2, Andrea Gruneir1,2,4, Vasily Giannakeas1,2, Jun Guan2, Kenneth Lam1,5, Miles J Luke1, Stephanie H Read1,2, Nathan M Stall1,3,5, Wei Wu1, Lynn Zhu1, Paula A Rochon1,2,3,5, Lisa M McCarthy1,6. 1. Women's College Research Institute, Women's College Hospital, Toronto, Ontario, Canada. 2. ICES, Toronto, Ontario, Canada. 3. Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. 4. Department of Family Medicine, University of Alberta, Edmonton, Alberta, Canada. 5. Division of Geriatric Medicine, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. 6. Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada.
Abstract
Importance: Calcium channel blockers (CCBs) are commonly prescribed agents for hypertension that can cause peripheral edema. A prescribing cascade occurs when the edema is misinterpreted as a new medical condition and a diuretic is subsequently prescribed to treat the edema. The extent to which this prescribing cascade occurs at a population level is not well understood. Objective: To measure the association between being newly dispensed a CCB and subsequent dispensing of a loop diuretic in older adults with hypertension. Design, Setting, and Participants: A population-based cohort study was performed using linked health administrative databases of community-dwelling adults 66 years or older with hypertension and new prescription drug claims from September 30, 2011, to September 30, 2016, in Ontario, Canada. The dates of analysis were September 1, 2018, to May 30, 2019. Exposures: Individuals who were newly dispensed a CCB were compared with the following 2 groups: (1) individuals who were newly dispensed an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker and (2) individuals who were newly dispensed an unrelated medication. Main Outcomes and Measures: Hazard ratios (HRs) with 95% CIs were estimated for individuals who were dispensed a loop diuretic within 90 days of follow-up using Cox proportional hazards regression models. Results: The cohort included 41 086 older adults (≥66 years) with hypertension who were newly dispensed a CCB, 66 494 individuals who were newly dispensed another antihypertensive medication, and 231 439 individuals who were newly dispensed an unrelated medication. At index (ie, the dispensing date), the mean (SD) age was 74.5 (6.9) years, and 191 685 (56.5%) were women. Individuals who were newly dispensed a CCB had a higher cumulative incidence at 90 days of being dispensed a loop diuretic than individuals in both control groups (1.4% vs 0.7% and 0.5%, P < .001). After adjustment, individuals who were newly dispensed a CCB had increased relative rates of being dispensed a loop diuretic compared with individuals who were newly dispensed an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker (HR, 1.68; 95% CI, 1.38-2.05 in the first 30 days after index [days 1-30]; 2.26; 95% CI, 1.76-2.92 in the subsequent 30 days [days 31-60]; and 2.40; 95% CI, 1.84-3.13 in the third month of follow-up [days 61-90]) and individuals who were newly dispensed unrelated medications (HR, 2.51; 95% CI, 2.13-2.96 for 1-30 days after index; 2.99; 95% CI, 2.43-3.69 for 31-60 days after index; and 3.89; 95% CI, 3.11-4.87 for 61-90 days after index). This association persisted, although slightly attenuated, from 90 days to up to 1 year of follow-up and when restricted to a subgroup of individuals who were newly dispensed amlodipine. Conclusions and Relevance: Many older adults with hypertension who are newly dispensed a CCB subsequently receive a loop diuretic. Given how widely CCBs are prescribed, interventions are needed to raise clinicians' awareness of this common prescribing cascade to reduce the prescribing of potentially unnecessary medications that may cause harm.
Importance: Calcium channel blockers (CCBs) are commonly prescribed agents for hypertension that can cause peripheral edema. A prescribing cascade occurs when the edema is misinterpreted as a new medical condition and a diuretic is subsequently prescribed to treat the edema. The extent to which this prescribing cascade occurs at a population level is not well understood. Objective: To measure the association between being newly dispensed a CCB and subsequent dispensing of a loop diuretic in older adults with hypertension. Design, Setting, and Participants: A population-based cohort study was performed using linked health administrative databases of community-dwelling adults 66 years or older with hypertension and new prescription drug claims from September 30, 2011, to September 30, 2016, in Ontario, Canada. The dates of analysis were September 1, 2018, to May 30, 2019. Exposures: Individuals who were newly dispensed a CCB were compared with the following 2 groups: (1) individuals who were newly dispensed an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker and (2) individuals who were newly dispensed an unrelated medication. Main Outcomes and Measures: Hazard ratios (HRs) with 95% CIs were estimated for individuals who were dispensed a loop diuretic within 90 days of follow-up using Cox proportional hazards regression models. Results: The cohort included 41 086 older adults (≥66 years) with hypertension who were newly dispensed a CCB, 66 494 individuals who were newly dispensed another antihypertensive medication, and 231 439 individuals who were newly dispensed an unrelated medication. At index (ie, the dispensing date), the mean (SD) age was 74.5 (6.9) years, and 191 685 (56.5%) were women. Individuals who were newly dispensed a CCB had a higher cumulative incidence at 90 days of being dispensed a loop diuretic than individuals in both control groups (1.4% vs 0.7% and 0.5%, P < .001). After adjustment, individuals who were newly dispensed a CCB had increased relative rates of being dispensed a loop diuretic compared with individuals who were newly dispensed an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker (HR, 1.68; 95% CI, 1.38-2.05 in the first 30 days after index [days 1-30]; 2.26; 95% CI, 1.76-2.92 in the subsequent 30 days [days 31-60]; and 2.40; 95% CI, 1.84-3.13 in the third month of follow-up [days 61-90]) and individuals who were newly dispensed unrelated medications (HR, 2.51; 95% CI, 2.13-2.96 for 1-30 days after index; 2.99; 95% CI, 2.43-3.69 for 31-60 days after index; and 3.89; 95% CI, 3.11-4.87 for 61-90 days after index). This association persisted, although slightly attenuated, from 90 days to up to 1 year of follow-up and when restricted to a subgroup of individuals who were newly dispensed amlodipine. Conclusions and Relevance: Many older adults with hypertension who are newly dispensed a CCB subsequently receive a loop diuretic. Given how widely CCBs are prescribed, interventions are needed to raise clinicians' awareness of this common prescribing cascade to reduce the prescribing of potentially unnecessary medications that may cause harm.
Authors: Carl J Pepine; Rhonda M Cooper-DeHoff; Robert J Weiss; Michael Koren; Neville Bittar; Udho Thadani; Margaret C Minkwitz; Eric L Michelson; Howard G Hutchinson Journal: Am J Cardiol Date: 2003-02-01 Impact factor: 2.778
Authors: Kara A Nerenberg; Kelly B Zarnke; Alexander A Leung; Kaberi Dasgupta; Sonia Butalia; Kerry McBrien; Kevin C Harris; Meranda Nakhla; Lyne Cloutier; Mark Gelfer; Maxime Lamarre-Cliche; Alain Milot; Peter Bolli; Guy Tremblay; Donna McLean; Raj S Padwal; Karen C Tran; Steven Grover; Simon W Rabkin; Gordon W Moe; Jonathan G Howlett; Patrice Lindsay; Michael D Hill; Mike Sharma; Thalia Field; Theodore H Wein; Ashkan Shoamanesh; George K Dresser; Pavel Hamet; Robert J Herman; Ellen Burgess; Steven E Gryn; Jean C Grégoire; Richard Lewanczuk; Luc Poirier; Tavis S Campbell; Ross D Feldman; Kim L Lavoie; Ross T Tsuyuki; George Honos; Ally P H Prebtani; Gregory Kline; Ernesto L Schiffrin; Andrew Don-Wauchope; Sheldon W Tobe; Richard E Gilbert; Lawrence A Leiter; Charlotte Jones; Vincent Woo; Robert A Hegele; Peter Selby; Andrew Pipe; Philip A McFarlane; Paul Oh; Milan Gupta; Simon L Bacon; Janusz Kaczorowski; Luc Trudeau; Norman R C Campbell; Swapnil Hiremath; Michael Roerecke; Joanne Arcand; Marcel Ruzicka; G V Ramesh Prasad; Michel Vallée; Cedric Edwards; Praveena Sivapalan; S Brian Penner; Anne Fournier; Geneviève Benoit; Janusz Feber; Janis Dionne; Laura A Magee; Alexander G Logan; Anne-Marie Côté; Evelyne Rey; Tabassum Firoz; Laura M Kuyper; Jonathan Y Gabor; Raymond R Townsend; Doreen M Rabi; Stella S Daskalopoulou Journal: Can J Cardiol Date: 2018-03-01 Impact factor: 5.223
Authors: Hana Brath; Nishila Mehta; Rachel D Savage; Sudeep S Gill; Wei Wu; Susan E Bronskill; Lynn Zhu; Jerry H Gurwitz; Paula A Rochon Journal: J Am Geriatr Soc Date: 2018-10-18 Impact factor: 5.562
Authors: Sarah D Berry; Murray A Mittleman; Yuqing Zhang; Daniel H Solomon; Lewis A Lipsitz; Elizabeth Mostofsky; Dana Goldense; Douglas P Kiel Journal: Pharmacoepidemiol Drug Saf Date: 2012-03-16 Impact factor: 2.890
Authors: Shelley A Sternberg; Mirko Petrovic; Graziano Onder; Antonio Cherubini; Denis O'Mahony; Jerry H Gurwitz; Francesco Pegreffi; Robin Mason; Jennifer Akerman; Lisa McCarthy; Andrea Lawson; Joyce Li; Wei Wu; Paula A Rochon Journal: Eur Geriatr Med Date: 2021-04-09 Impact factor: 1.710
Authors: Sarah Bloomstone; Kathryn Anzuoni; Noelle Cocoros; Jerry H Gurwitz; Kevin Haynes; Vinit P Nair; Richard Platt; Paula A Rochon; Sonal Singh; Kathleen M Mazor Journal: Ther Adv Drug Saf Date: 2020-10-30
Authors: Scott M Vouri; Earl J Morris; Silken A Usmani; Rachel Reise; Xinyi Jiang; Carl J Pepine; Todd M Manini; Daniel C Malone; Almut G Winterstein Journal: Pharmacoepidemiol Drug Saf Date: 2021-10-06 Impact factor: 2.890
Authors: Sonal Singh; Noelle M Cocoros; Kevin Haynes; Vinit P Nair; Thomas P Harkins; Paula A Rochon; Richard Platt; Inna Dashevsky; Juliane Reynolds; Kathleen M Mazor; Sarah Bloomstone; Kathryn Anzuoni; Sybil L Crawford; Jerry H Gurwitz Journal: J Am Geriatr Soc Date: 2021-01-11 Impact factor: 5.562